Ocumension Therapeutics Ownership
HK$5.32
0.76%
Hong Kong, Sep 17, 03:49 pm HKT.
Closed.
ISIN
KYG674111011
Symbol
1477
Industry
Ocumension Therapeutics Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Alcon AG
|
139.160m | 17.07% | — | Dec 31 2024 |
| 2 |
6 Dimensions Capital GP, LLC
|
126.200m | 15.48% | — | Dec 31 2024 |
| 3 |
Zhang (Qiping)
|
89.200m | 10.94% | -37.000m | Jul 01 2025 |
| 4 |
Boyu Capital Investment Management Limited
|
85.903m | 10.54% | — | Dec 31 2024 |
| 5 |
Liu (Ye)
|
40.919m | 5.02% | +1.080m | Sep 11 2025 |
|
1
Alcon AG
|
17.07%
139.160m
|
|
2
6 Dimensions Capital GP, LLC
|
15.48%
126.200m
|
|
3
Zhang (Qiping)
|
10.94%
89.200m
|
|
4
Boyu Capital Investment Management Limited
|
10.54%
85.903m
|
|
5
Liu (Ye)
|
5.02%
40.919m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 59.04% of Ocumension Therapeutics, with Alcon AG the biggest at 17.07%, followed by 6 Dimensions Capital GP, LLC (15.48%) and Zhang (Qiping) (10.94%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
